Create a Free Account
or
Create a Free Account
or
| # | Filing Date | Period End Date | Type | Report Link |
|---|---|---|---|---|
| No Data found | ||||
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Mizuho analyst Ann Hynes maintains Elevance Health (NYSE:ELV) with a Outperform and lowers the price target from $420 to $400.
JP Morgan analyst Lisa Gill maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $384 to ...
Charlie Bilello slams "absurd" gov't data claiming health insurance fell 18%. He says costs "only go in one dir...
US healthcare insurance providers Centene and Oscar Health stocks are down after Molina Healthcare reported disappointing guida...
TD Cowen analyst Ryan Langston maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $330 to $380.
Wells Fargo analyst Stephen Baxter maintains Elevance Health (NYSE:ELV) with a Overweight and lowers the price target from $...
Barclays analyst Andrew Mok maintains Elevance Health (NYSE:ELV) with a Overweight and lowers the price target from $395 to ...
Elevance Health beats estimates, but shares fall due to Medicare pressures, Obamacare changes, and Medicaid attrition.
